Governing, Protecting, and Regulating the Future of Genome Editing The Significance of ELSPI Perspectives
This edited collection examines the ethical, legal, social and policy implications of genome editing technologies. Moreover, it offers a broad spectrum of timely legal analysis related to bringing genome editing to the market and making it available to patients, including addressing genome editing t...
Saved in:
| Other Authors: | , , |
|---|---|
| Format: | Electronic Book Chapter |
| Language: | English |
| Published: |
Brill
2023
|
| Subjects: | |
| Online Access: | DOAB: download the publication DOAB: description of the publication |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000naaaa2200000uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_121419 | ||
| 005 | 20231116 | ||
| 003 | oapen | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 20231116s2023 xx |||||o ||| 0|eng d | ||
| 020 | |a 9789004526136 | ||
| 020 | |a 9789004526136 | ||
| 020 | |a 9789004526082 | ||
| 040 | |a oapen |c oapen | ||
| 024 | 7 | |a 10.1163/9789004526136 |c doi | |
| 041 | 0 | |a eng | |
| 042 | |a dc | ||
| 072 | 7 | |a LBBR |2 bicssc | |
| 072 | 7 | |a MFN |2 bicssc | |
| 100 | 1 | |a Slokenberga, Santa |4 edt | |
| 700 | 1 | |a Minssen, Timo |4 edt | |
| 700 | 1 | |a Nordberg, Ana |4 edt | |
| 700 | 1 | |a Slokenberga, Santa |4 oth | |
| 700 | 1 | |a Minssen, Timo |4 oth | |
| 700 | 1 | |a Nordberg, Ana |4 oth | |
| 245 | 1 | 0 | |a Governing, Protecting, and Regulating the Future of Genome Editing |b The Significance of ELSPI Perspectives |
| 260 | |b Brill |c 2023 | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a This edited collection examines the ethical, legal, social and policy implications of genome editing technologies. Moreover, it offers a broad spectrum of timely legal analysis related to bringing genome editing to the market and making it available to patients, including addressing genome editing technology regulation through procedures for regulatory approval, patent law and competition law. In twelve chapters, this volume offers persuasive arguments for justifying transformative regulatory interventions regarding human genome editing, as well as the various legal venues for introducing necessary or desirable changes needed to create an environment for realizing the potential of genome editing technology for the benefit of patients and society. | ||
| 536 | |a Lund University Medical Faculty Foundation | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a International human rights law |2 bicssc | |
| 650 | 7 | |a Medical genetics |2 bicssc | |
| 653 | |a Advanced Therapy Medicinal Products | ||
| 653 | |a Biomedicine Convention Article 13 | ||
| 653 | |a Clinical Trials Regulation Article 90 | ||
| 653 | |a CRISPR | ||
| 653 | |a Gene Therapy | ||
| 653 | |a Genetics and Justice | ||
| 653 | |a Germline genome editing | ||
| 653 | |a Health Innovation | ||
| 653 | |a Morality Exceptions | ||
| 653 | |a Ordre Public | ||
| 653 | |a Responsible Regulation | ||
| 653 | |a Somatic genome editing | ||
| 653 | |a Vulnerability and epigenome editing | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://library.oapen.org/bitstream/20.500.12657/76098/1/9789004526136.pdf |7 0 |z DOAB: download the publication |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/121419 |7 0 |z DOAB: description of the publication |